Comparison of medium-term adverse reactions induced by the first and second dose of mRNA BNT162b2 (Comirnaty, Pfizer-BioNTech) vaccine: a post-marketing Italian study conducted between 1 January and 28 February 2021 - Ossato, Andrea; Tessari, Roberto; Trabucchi, Carlotta; Zuppini, Teresa; Realdon, Nicola; Marchesini, Francesca (European journal of hospital pharmacy. Science and practice, 2023)
Keywords: Anaphylaxis; Asymptomatic; BNT162 Vaccine; COVID-19; COVID-19 - prevention & control; COVID-19 vaccines; drug monitoring; Drug-Related Side Effects and Adverse Reactions; evidence-based medicine; Fever; Gender; Headaches; hospital; Hospitals; Humans; Immunization; Infections; Italy - epidemiology; Lipids; Marketing; Original Research; Pain; Pandemics; Pharmacovigilance; Pharmacy; pharmacy service; Polyethylene glycol; Population; Prospective Studies; Public health; Questionnaires; RNA, Messenger; Severe acute respiratory syndrome coronavirus 2; Statistical analysis; United States; Vaccines; United States; Italy; COVID-19; pharmacy service; immunization; drug monitoring; drug-related side effects and adverse reactions; hospital; evidence-based medicine